232 related articles for article (PubMed ID: 24882272)
1. Dasatinib enhances migration of monocyte-derived dendritic cells by reducing phosphorylation of inhibitory immune receptors Siglec-9 and Siglec-3.
Nerreter T; Köchel C; Jesper D; Eichelbrönner I; Putz E; Einsele H; Seggewiss-Bernhardt R
Exp Hematol; 2014 Sep; 42(9):773-82.e1-3. PubMed ID: 24882272
[TBL] [Abstract][Full Text] [Related]
2. Src-kinase inhibitors sensitize human cells of myeloid origin to Toll-like-receptor-induced interleukin 12 synthesis.
Wölfl M; Schwinn S; Yoo YE; Reß ML; Braun M; Chopra M; Schreiber SC; Ayala VI; Ohlen C; Eyrich M; Beilhack A; Schlegel PG
Blood; 2013 Aug; 122(7):1203-13. PubMed ID: 23836556
[TBL] [Abstract][Full Text] [Related]
3. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
Milano F; van Baal JW; Rygiel AM; Bergman JJ; Van Deventer SJ; Kapsenberg ML; Peppelenbosch MP; Krishnadath KK
J Immunol Methods; 2007 Apr; 321(1-2):94-106. PubMed ID: 17336322
[TBL] [Abstract][Full Text] [Related]
4. Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation.
Büll C; Collado-Camps E; Kers-Rebel ED; Heise T; Søndergaard JN; den Brok MH; Schulte BM; Boltje TJ; Adema GJ
Immunol Cell Biol; 2017 Apr; 95(4):408-415. PubMed ID: 27874015
[TBL] [Abstract][Full Text] [Related]
5. Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells.
Nam S; Kim D; Cheng JQ; Zhang S; Lee JH; Buettner R; Mirosevich J; Lee FY; Jove R
Cancer Res; 2005 Oct; 65(20):9185-9. PubMed ID: 16230377
[TBL] [Abstract][Full Text] [Related]
6. Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
von Euw EM; Barrio MM; Furman D; Bianchini M; Levy EM; Yee C; Li Y; Wainstok R; Mordoh J
J Transl Med; 2007 Apr; 5():19. PubMed ID: 17448240
[TBL] [Abstract][Full Text] [Related]
7. The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro.
Blake S; Hughes TP; Mayrhofer G; Lyons AB
Clin Immunol; 2008 Jun; 127(3):330-9. PubMed ID: 18395492
[TBL] [Abstract][Full Text] [Related]
8. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
9. Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs.
Rubio MT; Means TK; Chakraverty R; Shaffer J; Fudaba Y; Chittenden M; Luster AD; Sykes M
Int Immunol; 2005 Dec; 17(12):1561-72. PubMed ID: 16303787
[TBL] [Abstract][Full Text] [Related]
10. Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation.
Arimoto-Miyamoto K; Kadowaki N; Kitawaki T; Iwata S; Morimoto C; Uchiyama T
Immunology; 2010 May; 130(1):137-49. PubMed ID: 20201989
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells.
Lock K; Zhang J; Lu J; Lee SH; Crocker PR
Immunobiology; 2004; 209(1-2):199-207. PubMed ID: 15481154
[TBL] [Abstract][Full Text] [Related]
12. Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses in vitro.
Nerreter T; Distler E; Köchel C; Einsele H; Herr W; Seggewiss-Bernhardt R
Exp Hematol; 2013 Jul; 41(7):604-614.e4. PubMed ID: 23466625
[TBL] [Abstract][Full Text] [Related]
13. CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cells.
Iijima N; Yanagawa Y; Clingan JM; Onoé K
Int Immunol; 2005 Sep; 17(9):1201-12. PubMed ID: 16027136
[TBL] [Abstract][Full Text] [Related]
14. The tyrosine kinase inhibitor dasatinib suppresses cytokine production by plasmacytoid dendritic cells by targeting endosomal transport of CpG DNA.
Fujita H; Kitawaki T; Sato T; Maeda T; Kamihira S; Takaori-Kondo A; Kadowaki N
Eur J Immunol; 2013 Jan; 43(1):93-103. PubMed ID: 23112129
[TBL] [Abstract][Full Text] [Related]
15. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
16. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes.
Conti L; Cardone M; Varano B; Puddu P; Belardelli F; Gessani S
Eur J Immunol; 2008 Mar; 38(3):750-62. PubMed ID: 18236400
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO.
Krause P; Singer E; Darley PI; Klebensberger J; Groettrup M; Legler DF
J Leukoc Biol; 2007 Nov; 82(5):1106-14. PubMed ID: 17698915
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib.
Wang L; Guo B; Wang R; Jiang Y; Qin S; Liang S; Zhao Y; Guo W; Li K; Fan X
Clin Sci (Lond); 2012 Jan; 122(1):13-24. PubMed ID: 21751967
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Siglec-8-induced intracellular reactive oxygen species production and eosinophil cell death by Src family kinases.
Kano G; Bochner BS; Zimmermann N
Immunobiology; 2017 Feb; 222(2):343-349. PubMed ID: 27682013
[TBL] [Abstract][Full Text] [Related]
20. Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo.
Fraser CK; Blake SJ; Diener KR; Lyons AB; Brown MP; Hughes TP; Hayball JD
Exp Hematol; 2009 Feb; 37(2):256-65. PubMed ID: 19056158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
